Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)

Clinical trial NCT05880524 · UNKNOWN

Trial details

NCT number: NCT05880524
Sponsor: Ludwig-Maximilians - University of Munich
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke Inflammatory Response

Start date: 2024-12-01
Primary completion: 2025-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.